New strength STALEVO

From 1st December 2008, a new strength of Stalevo 200/50/200 mg (levodopa 200 mg / carbidopa 50 mg / entacapone 200 mg) is available on the Pharmaceutical Benefits Scheme (PBS) providing physicians with more dosing options and flexibility for their patients with Parkinson’s disease (PD) who experience end-of-dose motor fluctuations.

Menu